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Abstract As of 1 May 2020, there had been 6808 confirmed cases of COVID-19 in Australia. Of
these, 98 had died from the disease. The epidemic had been in decline since mid-March, with 308
cases confirmed nationally since 14 April. This suggests that the collective actions of the Australian
public and government authorities in response to COVID-19 were sufficiently early and assiduous
to avert a public health crisis – for now. Analysing factors that contribute to individual country
experiences of COVID-19, such as the intensity and timing of public health interventions, will assist
in the next stage of response planning globally. We describe how the epidemic and public health
response unfolded in Australia up to 13 April. We estimate that the effective reproduction number
was likely below one in each Australian state since mid-March and forecast that clinical demand
would remain below capacity thresholds over the forecast period (from mid-to-late April).
Introduction
A small cluster of cases of the disease now known as COVID-19 was first reported on December 29,
2019, in the Chinese city of Wuhan (World Health Organization, 2020a). By early May 2020, the
disease had spread to all global regions, and overwhelmed some the world’s most developed health
systems. More than 2.8 million cases and 260,000 deaths had been confirmed globally, and the vast
majority of countries with confirmed cases were reporting escalating transmission (World Health
Organization, 2020b).
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As of 1 May 2020, there were 6808 confirmed cases of COVID-19 in Australia. Of these, 98 had
died from the disease. Encouragingly, the daily count of new confirmed cases had been declining
since late March 2020, with 308 cases reported nationally since 14 April (Australian Government
Department of Health, 2020a). This suggests that Australia has (to date) avoided a “worst-case”
scenario — one where planning models estimated a peak daily demand for 35,000 ICU beds by
around May 2020, far exceeding the health system’s capacity of around 2,200 ICU beds
(Moss et al., 2020).
The first wave of COVID-19 epidemics, and the government and public responses to them, have
varied vastly across the globe. For example, many European countries and the United States are in
the midst of explosive outbreaks with overwhelmed health systems (Remuzzi and Remuzzi, 2020;
The Lancet, 2020). Meanwhile, countries such as Singapore and South Korea had early success in
containing the spread, partly attributed to their extensive surveillance efforts and case targeted
interventions (Ng et al., 2020; COVID-19 National Emergency Response Center, Epidemiology
and Case Management Team, Korea Centers for Disease Control and Prevention, 2020). How-
ever, despite those early successes, Singapore has recently taken additional steps to further limit
transmission in the face of increasing importations and community spread (Government of Singa-
pore, 2020). Other locations in the region, including Taiwan, Hong Kong and New Zealand, have
had similar epidemic experiences, achieving control through a combination of border, case targeted
and social distancing measures.
Analysing key epidemiological and response factors — such as the intensity and timing of public
health interventions — that contribute to individual country experiences of COVID-19 will assist in
the next stage of response planning globally.
Here we describe the course of the COVID-19 epidemic and public health response in Australia
from 22 January up to mid-April 2020 (summarised in Figure 1). We then quantify the impact of the
public health response on disease transmission (Figure 2) and forecast the short-term health system
demand from COVID-19 patients (Figure 3).
Timeline of the Australian epidemic
Australia took an early and precautionary approach to COVID-19. On 1 February, when China was
the only country reporting uncontained transmission, Australian authorities restricted all travel from
mainland China to Australia, in order to reduce the risk of importation of the virus. Only Australian
citizens and residents (and their dependants) were permitted to travel from China to Australia. These
individuals were advised to self-quarantine for 14 days from their date of arrival. Further border
measures, including enhanced testing and provision of additional advice, were placed on arrivals
from other countries, based on a risk-assessment tool developed in early February (Shearer et al.,
2020).
The day before Australia imposed these restrictions (January 31), 9720 cases of COVID-19 had
been reported in mainland China (World Health Organization, 2020c). Australia had so far
detected and managed nine imported cases, all with recent travel history from or a direct epidemio-
logical link to Wuhan (Australian Government Department of Health, 2020b). Before the restric-
tions, Australia was expecting to receive approximately 200,000 air passengers from mainland China
during February 2020 (Australian Bureau of Statistics, 2019). Travel numbers fell dramatically fol-
lowing the imposed travel restrictions.
These restrictions were not intended (and highly unlikely [Errett et al., 2020]) to prevent the ulti-
mate importation of COVID-19 into Australia. Their purpose was to delay the establishment of an
epidemic, buying valuable time for health authorities to plan and prepare.
During the month of February, with extensive testing and case targeted interventions (case isola-
tion and contact quarantine) initiated from 29 January (Australian Government Department of
Health, 2020d), Australia detected and managed only 12 cases. Meanwhile, globally, the geo-
graphic extent of transmission and daily counts of confirmed cases and deaths continued to increase
drastically (World Health Organization, 2020d). In early March, Australia extended travel restric-
tions to a number of countries with large uncontained outbreaks, namely Iran (as of 1 March)
(Commonwealth Government of Australia, 2020a), South Korea (as of 5 March)
(Commonwealth Government of Australia, 2020b) and Italy (as of 11 March)
(Commonwealth Government of Australia, 2020c).
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Despite these measures, the daily case counts rose sharply in Australia during the first half of
March. While the vast majority of these cases were connected to travellers returning to Australia
from overseas, localised community transmission had been reported in areas of Sydney (NSW) and
Melbourne (VIC) (Australian Government Department of Health, 2020c). Crude plots of the cumu-
lative number of cases by country showed Australia on an early trajectory similar to the outbreaks
experienced in China, Europe and the United States, where health systems had become or were
becoming overwhelmed (Australian Government Department of Health, 2020f).
From 16 March, the Australian Government progressively implemented a range of social distanc-
ing measures in order to reduce and prevent further community transmission
(Commonwealth Government of Australia, 2020d). The day before, authorities had imposed a
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Figure 1. Time series of new daily confirmed cases of COVID-19 in Australia by import status (purple = overseas acquired, blue = locally acquired,
green = unknown origin) from 22 January 2020 (first case detected) to 13 April 2020. Dates of selected key border and social distancing measures
implemented by Australian authorities are indicated by annotations above the plotted case counts. These measures were in addition to case targeted
interventions (case isolation and contact quarantine) and further border measures, including enhanced testing and provision of advice, on arrivals from
other selected countries, based on a risk-assessment tool developed in early February (Shearer et al., 2020). Note that Australian citizens and
residents (and their dependants) were exempt from travel restrictions, but upon returning to Australia were required to quarantine for 14 days from the
date of arrival. A full timeline of social distancing and border measures is provided in Figure 1—figure supplement 2.
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. Time series of new daily confirmed cases of COVID-19 in each Australian state/territory by import status (purple = overseas
acquired, blue = locally acquired, green = unknown origin) from 22 January 2020 (first case detected) to 13 April 2020.
Figure supplement 2. Timeline of border and social distancing measures implemented in Australia up to 4 April 2020.
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self-quarantine requirement on all international arrivals (Commonwealth Government of Australia,
2020e). On 19 March, Australia closed its borders to all non-citizens and non-residents
(Commonwealth Government of Australia, 2020f), and on March 27, moved to a policy of manda-
tory quarantine for any returning citizens and residents (Commonwealth Government of Australia,
2020g). By 29 March, social distancing measures had been escalated to the extent that all Austral-
ians were strongly advised to leave their homes only for limited essential activities and public gather-
ings were limited to two people (Commonwealth Government of Australia, 2020h).
By late March, daily counts of new cases appeared to be declining, suggesting that these meas-
ures had successfully reduced transmission.
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Figure 2. Time-varying estimate of the effective reproduction number (Reff ) of COVID-19 by Australian state (light blue ribbon = 90% credible interval;
dark blue ribbon = 50% credible interval) from 1 March to 5 April 2020, based on data up to and including 13 April 2020. Confidence in the estimated
values is indicated by shading with reduced shading corresponding to reduced confidence. The horizontal dashed line indicates the target value of 1
for the effective reproduction number required for control. Not presented are the Australian Capital Territory (ACT), Northern Territory (NT) and
Tasmania (TAS), as these states/territories had insufficient local transmission. The uncertainty in the Reff estimates represent variability in a population-
level average as a result of imperfect data, rather than individual-level heterogeneity in transmission (i.e., the variation in the number of secondary cases
generated by each case).
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. Sensitivity analysis 1 of 3.
Figure supplement 2. Sensitivity analysis 2 of 3.
Figure supplement 3. Sensitivity analysis 3 of 3.
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Quantifying the impact of the response
Quantifying changes in the rate of spread of infection over the course of an epidemic is critical for
monitoring the collective impact of public health interventions and forecasting the short-term clinical
burden. A key indicator of transmission in context is the effective reproduction number (Reff ) — the
average number of secondary infections caused by an infected individual in the presence of public
health interventions and for which no assumption of 100% susceptibility is made. If control efforts
are able to bring Reff below 1, then on average there will be a decline in the number of new cases
reported. The decline will become apparent after a delay of approximately one incubation period
plus time to case detection and reporting following implementation of the control measure (i.e., at
least two weeks).
Using case counts from the Australian national COVID-19 database, we estimated Reff over time
for each Australian state from 24 February to 5 April 2020 (Figure 2). We used a statistical method
that estimates time-varying Reff by using an optimally selected moving average window (according
to the continuous ranked probability score) to smooth the curve and reduce the impact of localised
clusters and outbreaks that may cause large fluctuations (London School of Hygiene & Tropical
Medicine Mathematical Modelling of Infectious Diseases nCoV working group, 2020). Impor-
tantly, the method accounts for time delays between illness onset and case notification. Incorpo-
ration of this lag is critical for accurate interpretation of the most recent data in the analysis, to be
sure that an observed drop in the number of reported cases reflects an actual drop in case numbers.
Results show that Reff has likely been below one in each Australian state since early-to-mid March.
These estimates are geographically averaged results over large areas and it is possible that Reff was
much higher than one in a number of localised settings (see Figure 2). The estimated time-varying
Reff value is based on cases that have been identified as a result of local transmission, whereas
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Figure 3. Forecasted daily hospital ward (left) and intensive care unit (right) occupancy (dark ribbons = 50% confidence intervals; light ribbons = 95%
confidence intervals) from 17 March to 28 April. Occupancy = the number of beds occupied by COVID-19 patients on a given day. Black dots indicate
the reported ward and ICU occupancy available from the Australian national COVID-19 database at the time. These data were retrospectively updated
where complete data were available (red crosses). Australian health system ward and ICU bed capacities are estimated to be over 25,000 and 1,100,
respectively, under the assumption that 50% of total capacity could possibly be dedicated to COVID-19 patients (Australian Institute of Health and
Welfare, 2019). The forecasted daily case counts are shown in Figure 3—figure supplement 1.
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. Time series of new daily confirmed cases of COVID-19 in Australia from 1 March to 13 April 2020 (grey bars) overlaid by daily
case counts estimated from the forecasting model up to April 13 and projected forward from 14 to 28 April inclusive.
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imported cases only contribute to the force of infection. Imported and locally acquired cases were
assumed to be equally infectious. The method for estimating Reff is sensitive to this assumption.
Hence, we performed a sensitivity analysis to assess the impact of stepwise reductions in the infec-
tiousness of imported cases on Reff as a result of quarantine measures implemented over time (see
Figure 2—figure supplement 1, Figure 2—figure supplement 2, and Figure 2—figure supple-
ment 3). The sensitivity analyses suggest that Reff may well have dropped below one later than
shown in Figure 2.
In Victoria and New South Wales, the two Australian states with a substantial number of local
cases, the effective reproduction number likely dropped from marginally above one to well below
one within a two week period (considering both our main result and those from the sensitivity analy-
ses) coinciding with the implementation of social distancing measures. A comparable trend was
observed in New Zealand and many Western European countries, including France, Spain and Ger-
many (London School of Hygiene & Tropical Medicine Mathematical Modelling of Infectious Dis-
eases nCoV working group, 2020), where similar national, stage-wise social distancing policies
were enacted (Flaxman et al., 2020). However, most of these European countries experienced wide-
spread community transmission prior to the implementation of social distancing measures, with Reff
estimates reaching between 1.5 and 2 in early March and declining over a longer period (three to
four weeks) relative to Australia.
Forecasting the clinical burden
Next we used our estimates of time-varying Reff to forecast the short-term clinical burden in Aus-
tralia. Estimates were input into a mathematical model of disease dynamics that was extended to
account for imported cases. A sequential Monte Carlo method was used to infer the model parame-
ters and appropriately capture the uncertainty (Moss et al., 2019a), conditional on each of a number
of sampled Reff trajectories up to 5 April, from which point they were assumed to be constant. The
model was subsequently projected forward from April 14 to April 28, to forecast the number of
reported cases, assuming a symptomatic detection probability of 80%.
The number of new daily hospitalisations and ICU admissions were estimated from recently
observed and forecast case counts. Specifically, the age distribution of projected cases, and age-
specific probabilities of hospitalisation and ICU admission, were extracted from Australian age-spe-
cific data on confirmed cases, assuming that this distribution would remain unchanged (see Table 1).
In order to calculate the number of occupied ward/ICU beds per day, length-of-stay in a ward bed
and ICU bed were assumed to be Gamma distributed with means (SD) of 11 (3.42) days and 14
(5.22) days, respectively. Our results indicated that with the public health interventions in place as of
13 April, Australia’s hospital ward and ICU occupancy would remain well below capacity thresholds
over the period from 14 to 28 April.
Table 1. Age-specific proportions of confirmed cases extracted from the Australian national COVID-19 database and age-specific
estimates of the probability of hospitalisation and ICU admission for confirmed cases.
Age Proportion of cases Pr(hospitalisation | confirmed case) Pr(ICU admission | confirmed case)
0-9 0.0102 0.1475 0.0000
10-18 0.0186 0.1081 0.0090
19-29 0.2258 0.0504 0.0007
30-39 0.1587 0.0865 0.0074
40-49 0.1291 0.0947 0.0208
50-59 0.1550 0.1112 0.0173
60-69 0.1686 0.1529 0.0318
70-79 0.1050 0.2440 0.0558
80+ 0.0290 0.3815 0.0462
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Conclusions
Our analysis suggests that Australia’s combined strategy of early, targeted management of the risk
of importation, case targeted interventions, and broad-scale social distancing measures applied
prior to the onset of (detected) widespread community transmission has substantially mitigated the
first wave of COVID-19. More detailed analyses are required to assess the relative impact of specific
response measures, and this information will be crucial for the next phase of response planning.
Other factors, such as temperature, humidity and population density may influence transmission of
SARS-CoV-2 (Kissler et al., 2020). Whether these factors have played a role in the relative control of
SARS-CoV-2 in some countries, remains an open question. Noting that epidemics are established in
both the northern and southern hemispheres, it may be possible to gain insight into such factors
over the next six months, via for example a comparative analysis of transmission in Australia and
Europe.
We further anticipated that the Australian health care system was well positioned to manage the
projected COVID-19 case loads over the forecast period (up to 28 April). Ongoing situational assess-
ment and monitoring of forecast hospital and ICU demand will be essential for managing possible
future relaxation of broad-scale community interventions. Vigilance for localised increases in epi-
demic activity and in particular for outbreaks in vulnerable populations such as residential aged care
facilities, where a high proportion of cases are likely to be severe, must be maintained.
One largely unknown factor at present is the proportion of SARS-CoV-2 infections that are asymp-
tomatic, mild or undiagnosed. Even if this number is high, the Australian population would still be
largely susceptible to infection. Accordingly, complete relaxation of the measures currently in place
would see a rapid resurgence in epidemic activity. This problem is not unique to Australia. Many
countries with intensive social distancing measures in place are starting to grapple with their options
and time frames for a gradual return to relative normalcy (Gottlieb et al., 2020).
There are difficult decisions ahead for governments, and for now Australia is one of the few coun-
tries fortunate enough to be able to plan the next steps from a position of relative calm as opposed
to crisis.
Materials and methods
Estimating the time-varying effective reproduction number
Overview
The method used to estimate Reff is described in Cori et al., 2013, as implemented in the RXpack-
age,XEpiNow (Abbott et al., 2020). This method is currently in development by the Centre for the
Mathematical Modelling of Infectious Diseases at the London School of Hygiene and Tropical Medi-
cine (London School of Hygiene & Tropical Medicine Mathematical Modelling of Infectious Dis-
eases nCoV working group, 2020). Full details of their statistical analysis and code base is available
via their website (https://epiforecasts.io/covid/).
The uncertainty in the Reff estimates (shown in Figure 2; Figure 2—figure supplements 1, 2 and
3) represents variability in a population-level average as a result of imperfect data, rather than indi-
vidual-level heterogeneity in transmission (i.e., the variation in the number of secondary cases gener-
ated by each case). This is akin to the variation represented by a confidence interval (i.e., variation in
the estimate resulting from a finite sample), rather than a prediction interval (i.e., variation in individ-
ual observations).
We provide a brief overview of the method and sources of imperfect data below, focusing on
how the analysis was adapted to the Australian context.
Data
We used line-lists of reported cases for each Australian state/territory extracted from the national
COVID-19 database. The line-lists contain the date when the individual first exhibited symptoms,
date when the case notification was received by the jurisdictional health department and where the
infection was acquired (i.e., overseas or locally).
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Reporting delays and under-reporting
A pre-hoc statistical analysis was conducted in order to estimate a distribution of the reporting
delays from the line-lists of cases, using the code base provided by London School of Hygiene &
Tropical Medicine Mathematical Modelling of Infectious Diseases nCoV working group, 2020.
The estimated reporting delay is assumed to remain constant over time. These reporting delays are
used to: (i) infer the time of symptom onset for those without this information, and; (ii) infer how
many cases in recent days are yet to be recorded. Adjusting for reporting delays is critical for infer-
ring when a drop in observed cases reflects a true drop in cases.
Trends identified using this approach are robust to under-reporting, assuming that it is constant.
However, absolute values of Reff may be biased by reporting rates. Pronounced changes in reporting
rates may also impact the trends identified.
The delay from symptom onset to reporting is likely to decrease over the course of the epidemic,
due to improved surveillance and reporting. We used a delay distribution estimated from observed
reporting delays from the analysis period, which is therefore likely to underestimate reporting delays
early in the epidemic, and overestimate them as the epidemic progressed. Underestimating the
delay would result in an overestimate of Reff , as the inferred onset dates (for those that were
unknown) and adjustment for right-truncation, would result in more concentrated inferred daily cases
(i.e., the inferred cases would be more clustered in time than in reality). The converse would be true
when overestimating the delay. The impact of this misspecified distribution will be greatest on the
most recent estimates of Reff , where inference for both right-truncation and missing symptom onset
dates is required.
Estimating the effective reproduction number over time
Briefly, the Reff was estimated for each day from 24 February 2020 up to 5 April 2020 using line list
data – date of symptom onset, date of report, and import status – for each state. The method
assumes that the serial interval (i.e., time between symptom onset for an index and secondary case)
is uncertain, with a mean of 4.7 days (95% CrI: 3.7, 6.0) and a standard deviation of 2.9 days (95%
CrI: 1.9, 4.9), as estimated from early outbreak data in Wuhan, China (Nishiura et al., 2020). Com-
bining the incidence over time with the uncertain distribution of serial intervals allows us to estimate
Reff over time.
A different choice of serial interval distribution would affect the estimated time varying Reff . This
sensitivity is explored in detail in Flaxman et al., 2020, though we provide a brief description of the
impact here. For the same daily case data, a longer average serial interval would correspond to an
increased estimate of Reff when Reff>1, and a decreased estimate when Reff<1. This effect can be
understood intuitively by considering the epidemic dynamics in these two situations. When Reff>1 ,
daily case counts are increasing on average. The weighted average case counts (weighted by the
serial interval distribution), decrease as the mean of the serial interval increases (i.e., as the support
is shifted to older/lower daily case data). In order to generate the same number of observed cases in
the present, Reff must increase. A similar observation can be made for Reff<1.
In the context of our analyses (Figure 2), when the estimated Reff is above 1, assuming a longer
mean serial interval would further increase the Reff estimates in each jurisdiction (i.e., the upper 75%
of the Victorian posterior distribution for approximately the first 7–10 days, while stretching the
upper tails in the other jurisdictions). When the estimated Reff is below 1, a higher mean serial inter-
val would further decrease those estimates. Qualitatively, this does not impact on the time series of
Reff in each Australian jurisdiction.
A prior distribution was specified for Reff , with mean 2.6 (informed by Imai et al., 2020) and a
broad standard deviation of 2 so as to allow for a range of Reff values. Finally, Reff is estimated with a
moving average window, selected to optimise the continuous ranked probability score, in order to
smooth the curve and reduce the impact of localised events (i.e., cases clustered in time) causing
large variations.
Note that up to 20% of reported cases in the Australian national COVID-19 database do not have
a reported import status (see Figure 1). Conservatively, we assumed that all cases with an unknown
or unconfirmed source of acquisition were locally acquired.
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Accounting for imported cases
A large proportion of cases reported in Australia from January until now were imported from over-
seas. It is critical to account for two distinct populations in the case notification data – imported and
locally acquired – in order to perform robust analyses of transmission in the early stages of this out-
break. The estimated time-varying Reff value is based on cases that have been identified as a result
of local transmission, whereas imported cases contribute to transmission only (Thompson et al.,
2019).
Specifically, the method assumes that local and imported cases contribute equally to transmis-
sion. The results under this assumption are presented in Figure 2. However, it is likely that imported
cases contributed relatively less to transmission than locally acquired cases, as a result of quarantine
and other border measures which targeted these individuals (Figure 1—figure supplement 2). In
the absence of data on whether the infector of local cases was themselves an imported or local case
(from which we could robustly estimate the contribution of imported cases to transmission), we
explored this via a sensitivity analysis. We aimed to explore the impact of a number of plausible sce-
narios, based on our knowledge of the timing, extent and level of enforcement of different quaran-
tine policies enacted over time.
Prior to 15 March, returning Australian residents and citizens (and their dependents) from main-
land China were advised to self-quarantine. Note that further border measures were implemented
during this period, including enhanced testing and provision of advice on arrivals from selected
countries based on a risk assessment tool developed in early February (Shearer et al., 2020). On 15
March, Australian authorities imposed a self-quarantine requirement on all international arrivals, and
from 27 March, moved to a mandatory quarantine policy for all international arrivals.
Hence for the sensitivity analysis, we assumed two step changes in the effectiveness of quarantine
of overseas arrivals (timed to coincide with the two key policy changes), resulting in three interven-
tion phases: prior to 15 March (self-quarantine of arrivals from selected countries); 15–27 March
inclusive (self-quarantine of arrivals from all countries); and 27 March onward (mandatory quarantine
of overseas arrivals from all countries). We further assumed that the relative infectiousness of
imported cases decreased with each intervention phase. The first two intervention phases corre-
spond to self-quarantine policies, so we assume that they resulted in a relatively small reduction in
the relative infectiousness of imported cases (the first smaller than the second, since the pre-15
March policy only applied to arrivals from selected countries). The third intervention phase corre-
sponds to mandatory quarantine of overseas arrivals in hotels which we assume is highly effective at
reducing onward transmission from imported cases, but allows for the occasional transmission event.
We then varied the percentage of imported cases contributing to transmission over the three inter-
vention phases, as detailed in Table 2.
Forecasting short-term ward and ICU bed occupancy
We used the estimates of time-varying Reff to forecast the national short-term ward/ICU occupancy
due to COVID-19 patients.
Table 2. Percentage of imported cases assumed to be contributing to transmission over three
intervention phases for each sensitivity analysis.
We assume two step changes in the effectiveness of quarantine of overseas arrivals, resulting in three
intervention phases: prior to 15 March (self-quarantine of arrivals from selected countries); 15–27
March inclusive (self-quarantine of arrivals from all countries); and 27 March onward (mandatory quar-
antine of overseas arrivals from all countries).
Imported cases contributing to transmission
Sensitivity analysis Prior to 15 March 15–27 March 27 March–
1 90% 50% 1%
2 80% 50% 1%
3 50% 20% 1%
The results of these three analyses are shown in Figure 2—figure supplements 1, 2 and 3, respectively.
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Forecasting case counts
The forecasting method combines an SEEIIR (susceptible-exposed-infectious-recovered) population
model of infection with daily COVID-19 case notification counts, through the use of a bootstrap par-
ticle filter (Arulampalam et al., 2002). This approach is similar to that implemented and described in
Moss et al., 2019b, in the context of seasonal influenza forecasts for several major Australian cities.
Briefly, the particle filter method uses post-regularisation (Doucet et al., 2001), with a deterministic
resampling stage (Kitagawa, 1996). Code and documentation are available at https://epifx.readthe-
docs.io/en/latest/. The daily case counts by date of diagnosis were modelled using a negative bino-
mial distribution with a fixed dispersion parameter k, and the expected number of cases was
proportional to the daily incidence of symptomatic infections in the SEEIIR model; this proportion
was characterised by the observation probability. Natural disease history parameters were sampled
from narrow uniform priors, based on values reported in the literature for COVID-19 (Table 3), and
each particle was associated with an Reff trajectory that was drawn from the state/territory Reff trajec-
tories in Figure 2 up to 5 April, from which point they are assumed to be constant. The model was
subsequently projected forward from April 14 to April 28, to forecast the number of reported cases,
assuming a detection probability of 80%.
In order to account for imported cases, we used daily counts of imported cases to construct a
time-series of the expected daily importation rate and, assuming that such cases were identified one
week after initial exposure, introduced exposure events into each particle trajectory by adding an
extra term to the force of infection equation.
Model equations below describe the flow of individuals in the population from the susceptible
class (S), through two exposed classes (E1, E2), two infectious classes (I1, I2) and finally into a
removed class (R). The state variables S;E1;E2; I1; I2;R correspond to the proportion of individuals in
the population (of size N) in each compartment. Given the closed population and unidirectional flow
of individuals through the compartments, we evaluate the daily incidence of symptomatic individuals
(at time t) as the change in cumulative incidence (the bracketed term in the expression for E½yt
below). Two exposed and infectious classes are chosen such that the duration of time in the exposed
or infectious period has an Erlang distribution. The corresponding parameters are given in Table 2.
Model equations:
dS
dt
¼ bðtÞ  SðI1þ I2Þ
dE1
dt
¼ bðtÞ  SðI1þ I2Þ  2sE1
dE2
dt
¼ 2sE1  2sE2
dI1
dt
¼ 2sE2  2gI1
dI2
dt
¼ 2gI1  2gI2
dR
dt
¼ 2gI2
With initial conditions:
Sð0Þ ¼ N 10
N
E1ð0Þ ¼
10
N
E2ð0Þ ¼ I1ð0Þ ¼ I2ð0Þ ¼ Rð0Þ ¼ 0
Observation model:
E½yt ¼N  pobs  I2ðtÞþRðtÞ  ðI2ðt  1ÞþRðt  1ÞÞ½ 
xt ¼ ½SðtÞ;E1ðtÞ;E2ðtÞ; I1ðtÞ; I2ðtÞ;RðtÞ;b
iðtÞ;s;g;t 
Lðyt j xtÞ ~NegBinðE½yt;kÞ
With time-varying transmission rate corresponding to Reff trajectory i:
biðtÞ ¼
0; if t<t
Rieff ðtÞ g; if t t ;

for i 2 f1;2; :::;10g
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Forecasting ward and ICU bed occupancy from observed and projected
case counts
The number of new daily hospitalisations and ICU admissions were estimated from recently observed
and forecasted case counts by:
1. Estimating the age distribution of projected case counts using data from the national COVID-
19 database on the age-specific proportion of confirmed cases;
2. Estimating the age-specific hospitalisation and ICU admission rates using data from the
national COVID-19 database. We assumed that all hospitalisations and ICU admissions were
either recorded or were missing at random (31% and 58% of cases had no information
recorded under hospitalisation or ICU status, respectively);
3. Randomly drawing the number of hospitalisations/ICU admissions in each age-group (for both
the observed and projected case counts) from a binomial distribution with number of trials
given by the expected number of cases in each age group (from 1), and probability given by
the observed proportion of hospitalisations/ICU admissions by age group (from 2).
Finally, in order to calculate the number of occupied ward/ICU beds per day, length-of-stay in a
ward bed and ICU bed were assumed to be Gamma distributed with means (SD) of 11 (3.42) days
and 14 (5.22) days, respectively. We assumed ICU admissions required a ward bed prior to, and fol-
lowing, ICU stay for a Poisson distributed number of days with mean 2.5. Relevant Australian data
were not available to parameterise a model that captures the dynamics of patient flow within the
hospital system in more detail. Instead, these distributions were informed by a large study of clinical
characteristics of 1099 COVID-19 patients in China (Guan et al., 2020). This model provides a useful
indication of hospital bed occupancy based on limited available data and may be updated as more
specific data (e.g., on COVID-19 patient length-of-stay) becomes available.
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